2m 2m 2m 2m 2m 2m 2m
ENGENE THERAP (ENGN)
NASDAQ
$1.80+$0.002 (+0.11%)
Price as of Sep 11, 2026 7:56 PM EDT- $120.6MMarket Cap
- -68.48%1-Year Change
- BiotechnologyIndustry
ENGENE THERAP (ENGN)
$1.80+$0.002 (+0.11%)
ENGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.80 | ||
Change | +$0.03 (+1.69%) | ||
Open | $1.80 | ||
High | $1.83 | ||
Low | $1.79 | ||
Previous Close | $1.77 | ||
Volume | 651,007 | ||
30-Day Average Volume | 758,718 | ||
1-Week Change | -1.10% | ||
1-Month Change | -1.10% | ||
1-Year Change | -68.48% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 67.0M | ||
Total Assets | $288.3M | ||
Market Cap | $120.6M | ||
Enterprise Value | $105.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.5M | ||
Free Cash Flow | -$18.9M | ||
EBIT | -$31.7M | ||
EBITDA | -$31.5M | ||
Net Working Capital | $250.7M | ||
EPS | -$0.47 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 08/03/2015 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue